Annual Gross Profit
$61.94 M
+$9.14 M+17.31%
31 December 2023
Summary:
Heron Therapeutics annual gross profit is currently $61.94 million, with the most recent change of +$9.14 million (+17.31%) on 31 December 2023. During the last 3 years, it has risen by +$9.49 million (+18.09%). HRTX annual gross profit is now -26.57% below its all-time high of $84.35 million, reached on 31 December 2019.HRTX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$23.35 M
-$2.15 M-8.45%
30 September 2024
Summary:
Heron Therapeutics quarterly gross profit is currently $23.35 million, with the most recent change of -$2.15 million (-8.45%) on 30 September 2024. Over the past year, it has increased by +$10.13 million (+76.56%). HRTX quarterly gross profit is now -10.96% below its all-time high of $26.23 million, reached on 31 March 2024.HRTX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$99.43 M
+$10.13 M+11.34%
30 September 2024
Summary:
Heron Therapeutics TTM gross profit is currently $99.43 million, with the most recent change of +$10.13 million (+11.34%) on 30 September 2024. Over the past year, it has increased by +$44.44 million (+80.81%). HRTX TTM gross profit is now at all-time high.HRTX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HRTX Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.3% | +76.6% | +80.8% |
| 3 y3 years | +18.1% | +96.6% | +137.7% |
| 5 y5 years | +24.0% | -8.2% | +20.6% |
HRTX Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +53.6% | -11.0% | +140.4% | at high | +146.6% |
| 5 y | 5 years | -26.6% | +53.6% | -11.0% | +194.8% | at high | +146.6% |
| alltime | all time | -26.6% | -11.0% | +714.5% | at high |
Heron Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.35 M(-8.4%) | $99.43 M(+11.3%) |
| June 2024 | - | $25.51 M(-2.7%) | $89.31 M(+18.4%) |
| Mar 2024 | - | $26.23 M(+7.7%) | $75.40 M(+21.7%) |
| Dec 2023 | $61.94 M(+17.3%) | $24.35 M(+84.1%) | $61.94 M(+12.6%) |
| Sept 2023 | - | $13.23 M(+14.0%) | $54.99 M(+2.6%) |
| June 2023 | - | $11.60 M(-9.1%) | $53.61 M(+0.3%) |
| Mar 2023 | - | $12.76 M(-26.7%) | $53.46 M(+1.2%) |
| Dec 2022 | $52.80 M(+30.9%) | $17.40 M(+47.0%) | $52.80 M(+17.0%) |
| Sept 2022 | - | $11.84 M(+3.4%) | $45.11 M(-0.1%) |
| June 2022 | - | $11.46 M(-5.3%) | $45.15 M(+8.5%) |
| Mar 2022 | - | $12.10 M(+24.6%) | $41.62 M(+3.2%) |
| Dec 2021 | $40.33 M(-23.1%) | $9.71 M(-18.2%) | $40.33 M(-3.6%) |
| Sept 2021 | - | $11.88 M(+50.0%) | $41.82 M(-2.1%) |
| June 2021 | - | $7.92 M(-26.7%) | $42.74 M(-11.8%) |
| Mar 2021 | - | $10.81 M(-3.6%) | $48.48 M(-7.6%) |
| Dec 2020 | $52.45 M(-37.8%) | $11.21 M(-12.4%) | $52.45 M(-13.2%) |
| Sept 2020 | - | $12.79 M(-6.4%) | $60.45 M(-17.3%) |
| June 2020 | - | $13.66 M(-7.5%) | $73.08 M(-11.4%) |
| Mar 2020 | - | $14.78 M(-23.1%) | $82.49 M(-2.2%) |
| Dec 2019 | $84.35 M(+68.8%) | $19.21 M(-24.5%) | $84.35 M(+2.4%) |
| Sept 2019 | - | $25.43 M(+10.2%) | $82.41 M(+19.1%) |
| June 2019 | - | $23.07 M(+38.6%) | $69.19 M(+19.0%) |
| Mar 2019 | - | $16.64 M(-3.7%) | $58.17 M(+16.4%) |
| Dec 2018 | $49.96 M(+90.8%) | $17.27 M(+41.5%) | $49.96 M(+20.7%) |
| Sept 2018 | - | $12.21 M(+1.4%) | $41.41 M(+12.8%) |
| June 2018 | - | $12.05 M(+42.8%) | $36.72 M(+14.1%) |
| Mar 2018 | - | $8.43 M(-3.2%) | $32.17 M(+22.9%) |
| Dec 2017 | $26.18 M(+2004.4%) | $8.71 M(+15.9%) | $26.18 M(+39.9%) |
| Sept 2017 | - | $7.52 M(+0.3%) | $18.71 M(+67.2%) |
| June 2017 | - | $7.50 M(+206.5%) | $11.19 M(+203.2%) |
| Mar 2017 | - | $2.45 M(+96.6%) | $3.69 M(+196.6%) |
| Dec 2016 | $1.24 M(>+9900.0%) | $1.24 M(>+9900.0%) | $1.24 M(>+9900.0%) |
| Sept 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2015 | $0.00(0.0%) | - | - |
| Dec 2014 | $0.00(-100.0%) | - | - |
| Sept 2011 | - | $0.00(-100.0%) | $646.00 K(-35.2%) |
| June 2011 | - | $251.00 K(-36.5%) | $997.00 K(-21.9%) |
| Mar 2011 | - | $395.00 K(+12.5%) | $1.28 M(+2.6%) |
| Sept 2010 | - | $351.00 K(-33.8%) | $1.24 M(-38.1%) |
| June 2010 | - | $530.00 K(+119.9%) | $2.01 M(+34.5%) |
| Mar 2010 | - | $241.00 K(+97.5%) | $1.49 M(+18.5%) |
| Dec 2009 | $1.26 M(+241.7%) | $122.00 K(-89.1%) | $1.26 M(+8.7%) |
| Sept 2009 | - | $1.12 M(+7878.6%) | $1.16 M(+984.1%) |
| June 2009 | - | $14.00 K(+75.0%) | $107.00 K(+15.1%) |
| Mar 2009 | - | $8000.00(-61.9%) | $93.00 K(+9.4%) |
| Dec 2008 | $369.00 K | $21.00 K(-67.2%) | $85.00 K(+32.8%) |
| Sept 2008 | - | $64.00 K(-94.8%) | $64.00 K(-97.3%) |
| Sept 2002 | - | $1.23 M(+8.2%) | $2.38 M(+17.4%) |
| June 2002 | - | $1.14 M(+29.5%) | $2.02 M(-39.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2001 | - | $881.30 K(-0.6%) | $3.33 M(+3.5%) |
| June 2001 | - | $886.90 K(+1.1%) | $3.22 M(+4.9%) |
| Mar 2001 | - | $877.40 K(+27.7%) | $3.07 M(+9.7%) |
| Dec 2000 | $2.87 M(-34.8%) | $687.30 K(-10.7%) | $2.80 M(-11.8%) |
| Sept 2000 | - | $769.90 K(+4.4%) | $3.18 M(-1.4%) |
| June 2000 | - | $737.20 K(+21.7%) | $3.22 M(-43.3%) |
| Mar 2000 | - | $605.80 K(-43.0%) | $5.68 M(-34.5%) |
| Dec 1999 | $4.40 M(+51.7%) | $1.06 M(+30.6%) | $8.68 M(+127.5%) |
| Sept 1999 | - | $814.20 K(-74.6%) | $3.81 M(-38.5%) |
| June 1999 | - | $3.20 M(-11.1%) | $6.20 M(-4.6%) |
| Mar 1999 | - | $3.60 M(-194.7%) | $6.50 M(+6.6%) |
| Dec 1998 | $2.90 M(-71.8%) | -$3.80 M(-218.8%) | $6.10 M(-44.5%) |
| Sept 1998 | - | $3.20 M(-8.6%) | $11.00 M(+6.8%) |
| June 1998 | - | $3.50 M(+9.4%) | $10.30 M(+8.4%) |
| Mar 1998 | - | $3.20 M(+190.9%) | $9.50 M(-5.9%) |
| Dec 1997 | $10.30 M(+10.8%) | $1.10 M(-56.0%) | $10.10 M(-4.7%) |
| Sept 1997 | - | $2.50 M(-7.4%) | $10.60 M(-0.9%) |
| June 1997 | - | $2.70 M(-28.9%) | $10.70 M(-0.9%) |
| Mar 1997 | - | $3.80 M(+137.5%) | $10.80 M(+16.1%) |
| Dec 1996 | $9.30 M(+47.6%) | $1.60 M(-38.5%) | $9.30 M(+9.4%) |
| Sept 1996 | - | $2.60 M(-7.1%) | $8.50 M(+14.9%) |
| June 1996 | - | $2.80 M(+21.7%) | $7.40 M(+17.5%) |
| Mar 1996 | - | $2.30 M(+187.5%) | $6.30 M(-1.6%) |
| Dec 1995 | $6.30 M(-8.7%) | $800.00 K(-46.7%) | $6.40 M(-20.0%) |
| Sept 1995 | - | $1.50 M(-11.8%) | $8.00 M(+8.1%) |
| June 1995 | - | $1.70 M(-29.2%) | $7.40 M(+1.4%) |
| Mar 1995 | - | $2.40 M(0.0%) | $7.30 M(+7.4%) |
| Dec 1994 | $6.90 M(-16.9%) | $2.40 M(+166.7%) | $6.80 M(+1.5%) |
| Sept 1994 | - | $900.00 K(-43.8%) | $6.70 M(-11.8%) |
| June 1994 | - | $1.60 M(-15.8%) | $7.60 M(-3.8%) |
| Mar 1994 | - | $1.90 M(-17.4%) | $7.90 M(+9.7%) |
| Dec 1993 | $8.30 M(+137.1%) | $2.30 M(+27.8%) | $7.20 M(+33.3%) |
| Sept 1993 | - | $1.80 M(-5.3%) | $5.40 M(+12.5%) |
| June 1993 | - | $1.90 M(+58.3%) | $4.80 M(+9.1%) |
| Mar 1993 | - | $1.20 M(+140.0%) | $4.40 M(+29.4%) |
| Dec 1992 | $3.50 M(+105.9%) | $500.00 K(-58.3%) | $3.40 M(+13.3%) |
| Sept 1992 | - | $1.20 M(-20.0%) | $3.00 M(+50.0%) |
| June 1992 | - | $1.50 M(+650.0%) | $2.00 M(+17.6%) |
| Mar 1992 | - | $200.00 K(+100.0%) | $1.70 M(0.0%) |
| Dec 1991 | $1.70 M(+41.7%) | $100.00 K(-50.0%) | $1.70 M(-10.5%) |
| Sept 1991 | - | $200.00 K(-83.3%) | $1.90 M(0.0%) |
| June 1991 | - | $1.20 M(+500.0%) | $1.90 M(+58.3%) |
| Mar 1991 | - | $200.00 K(-33.3%) | $1.20 M(-7.7%) |
| Dec 1990 | $1.20 M(-42.9%) | $300.00 K(+50.0%) | $1.30 M(0.0%) |
| Sept 1990 | - | $200.00 K(-60.0%) | $1.30 M(-13.3%) |
| June 1990 | - | $500.00 K(+66.7%) | $1.50 M(-31.8%) |
| Mar 1990 | - | $300.00 K(0.0%) | $2.20 M(+15.8%) |
| Dec 1989 | $2.10 M(+10.5%) | $300.00 K(-25.0%) | $1.90 M(+18.8%) |
| Sept 1989 | - | $400.00 K(-66.7%) | $1.60 M(+33.3%) |
| June 1989 | - | $1.20 M | $1.20 M |
| Dec 1988 | $1.90 M(+46.2%) | - | - |
| Dec 1987 | $1.30 M | - | - |
FAQ
- What is Heron Therapeutics annual gross profit?
- What is the all time high annual gross profit for Heron Therapeutics?
- What is Heron Therapeutics annual gross profit year-on-year change?
- What is Heron Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Heron Therapeutics?
- What is Heron Therapeutics quarterly gross profit year-on-year change?
- What is Heron Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Heron Therapeutics?
- What is Heron Therapeutics TTM gross profit year-on-year change?
What is Heron Therapeutics annual gross profit?
The current annual gross profit of HRTX is $61.94 M
What is the all time high annual gross profit for Heron Therapeutics?
Heron Therapeutics all-time high annual gross profit is $84.35 M
What is Heron Therapeutics annual gross profit year-on-year change?
Over the past year, HRTX annual gross profit has changed by +$9.14 M (+17.31%)
What is Heron Therapeutics quarterly gross profit?
The current quarterly gross profit of HRTX is $23.35 M
What is the all time high quarterly gross profit for Heron Therapeutics?
Heron Therapeutics all-time high quarterly gross profit is $26.23 M
What is Heron Therapeutics quarterly gross profit year-on-year change?
Over the past year, HRTX quarterly gross profit has changed by +$10.13 M (+76.56%)
What is Heron Therapeutics TTM gross profit?
The current TTM gross profit of HRTX is $99.43 M
What is the all time high TTM gross profit for Heron Therapeutics?
Heron Therapeutics all-time high TTM gross profit is $99.43 M
What is Heron Therapeutics TTM gross profit year-on-year change?
Over the past year, HRTX TTM gross profit has changed by +$44.44 M (+80.81%)